Cariprazine as a treatment across the bipolar I spectrum from depression to mania: mechanism of action and review of clinical data
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cariprazine as a treatment across the bipolar I spectrum from depression to mania: mechanism of action and review of clinical data
Authors
Keywords
-
Journal
Therapeutic Advances in Psychopharmacology
Volume 10, Issue -, Pages 204512532090575
Publisher
SAGE Publications
Online
2020-02-12
DOI
10.1177/2045125320905752
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cariprazine Treatment of Bipolar Depression: A Randomized Double-Blind Placebo-Controlled Phase 3 Study
- (2019) Willie Earley et al. AMERICAN JOURNAL OF PSYCHIATRY
- Mixed mood states: Baffled, bewildered, befuddled and bemused
- (2019) Stephen M. Stahl et al. BIPOLAR DISORDERS
- Novel antipsychotics specificity profile: A clinically oriented review of lurasidone, brexpiprazole, cariprazine and lumateperone
- (2019) Filippo Corponi et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Preclinical pharmacodynamic and pharmacokinetic characterization of the major metabolites of cariprazine
- (2019) Béla Kiss et al. Drug Design Development and Therapy
- Cariprazine in the treatment of Bipolar Disorder: A systematic review and meta‐analysis
- (2019) Jairo Vinícius Pinto et al. BIPOLAR DISORDERS
- Cariprazine efficacy in bipolar I depression with and without concurrent manic symptoms: post hoc analysis of 3 randomized, placebo-controlled studies
- (2019) Roger S. McIntyre et al. CNS SPECTRUMS
- Cariprazine for the treatment of bipolar mania with mixed features: A post hoc pooled analysis of 3 trials
- (2019) Roger S. McIntyre et al. JOURNAL OF AFFECTIVE DISORDERS
- Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder
- (2018) Lakshmi N Yatham et al. BIPOLAR DISORDERS
- The safety and tolerability of cariprazine in patients with manic or mixed episodes associated with bipolar I disorder: A 16-week open-label study
- (2018) Terence A. Ketter et al. JOURNAL OF AFFECTIVE DISORDERS
- Cariprazine In Bipolar Depression And Mania: State Of The Art
- (2018) Marianna Mazza et al. CNS & Neurological Disorders-Drug Targets
- Efficacy of adjunctive low-dose cariprazine in major depressive disorder
- (2018) Maurizio Fava et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- Cariprazine specificity profile in the treatment of acute schizophrenia
- (2017) Filippo Corponi et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- Cariprazine Exhibits Anxiolytic and Dopamine D3 Receptor-Dependent Antidepressant Effects in the Chronic Stress Model
- (2017) Vanja Duric et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Cariprazine versus risperidone monotherapy for treatment of predominant negative symptoms in patients with schizophrenia: a randomised, double-blind, controlled trial
- (2017) György Németh et al. LANCET
- The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Acute and long-term treatment of mixed states in bipolar disorder
- (2017) Heinz Grunze et al. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
- An 8-Week Randomized, Double-Blind, Placebo-Controlled Evaluation of the Safety and Efficacy of Cariprazine in Patients With Bipolar I Depression
- (2016) Suresh Durgam et al. AMERICAN JOURNAL OF PSYCHIATRY
- Mechanism of action of cariprazine
- (2016) Stephen M. Stahl CNS SPECTRUMS
- The Novel Antipsychotic Cariprazine (RGH-188): State-of-the-Art in the Treatment of Psychiatric Disorders
- (2016) Domenico Berardis et al. CURRENT PHARMACEUTICAL DESIGN
- Efficacy and Safety of Adjunctive Cariprazine in Inadequate Responders to Antidepressants
- (2016) Suresh Durgam et al. JOURNAL OF CLINICAL PSYCHIATRY
- Cariprazine in the treatment of acute mania in bipolar I disorder: A double-blind, placebo-controlled, Phase III trial
- (2015) Gary S. Sachs et al. JOURNAL OF AFFECTIVE DISORDERS
- The efficacy and tolerability of cariprazine in acute mania associated with bipolar I disorder: a phase II trial
- (2014) Suresh Durgam et al. BIPOLAR DISORDERS
- Efficacy and Safety of Low- and High-Dose Cariprazine in Acute and Mixed Mania Associated With Bipolar I Disorder
- (2014) Joseph R. Calabrese et al. JOURNAL OF CLINICAL PSYCHIATRY
- Dopamine D3 receptor as a new pharmacological target for the treatment of depression
- (2013) Gian Marco Leggio et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- A proposal for an updated neuropsychopharmacological nomenclature
- (2013) Joseph Zohar et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Cariprazine: chemistry, pharmacodynamics, pharmacokinetics, and metabolism, clinical efficacy, safety, and tolerability
- (2013) Leslie Citrome Expert Opinion on Drug Metabolism & Toxicology
- Cariprazine, a dopamine D3-receptor-preferring partial agonist, blocks phencyclidine-induced impairments of working memory, attention set-shifting, and recognition memory in the mouse
- (2012) Ross Zimnisky et al. PSYCHOPHARMACOLOGY
- Cariprazine (RGH-188), a potent D3/D2 dopamine receptor partial agonist, binds to dopamine D3 receptors in vivo and shows antipsychotic-like and procognitive effects in rodents
- (2011) István Gyertyán et al. NEUROCHEMISTRY INTERNATIONAL
- Cariprazine (RGH-188), a Dopamine D3 Receptor-Preferring, D3/D2 Dopamine Receptor Antagonist-Partial Agonist Antipsychotic Candidate: In Vitro and Neurochemical Profile
- (2010) B. Kiss et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now